CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Free Cash Flow: -72.98M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -72.98M |
| September 30, 2023 | -64.18M |
| June 30, 2023 | -55.57M |
| March 31, 2023 | -52.63M |
| December 31, 2022 | -84.23M |
| September 30, 2022 | -79.70M |
| June 30, 2022 | -77.58M |
| March 31, 2022 | -74.22M |
| December 31, 2021 | -69.52M |
| September 30, 2021 | -70.09M |
| June 30, 2021 | -62.15M |
| March 31, 2021 | -50.69M |
| December 31, 2020 | -44.75M |
| September 30, 2020 | -58.09M |
| June 30, 2020 | -73.77M |
| March 31, 2020 | -90.36M |
| December 31, 2019 | -98.23M |
| September 30, 2019 | -90.13M |
| June 30, 2019 | -83.07M |
| March 31, 2019 | -71.55M |
| December 31, 2018 | -55.46M |
| Date | Value |
|---|---|
| September 30, 2018 | -41.47M |
| June 30, 2018 | -30.85M |
| March 31, 2018 | -23.92M |
| December 31, 2017 | -19.63M |
| September 30, 2017 | -18.96M |
| June 30, 2017 | -19.24M |
| March 31, 2017 | -19.46M |
| December 31, 2016 | -23.40M |
| September 30, 2016 | -23.19M |
| June 30, 2016 | -24.10M |
| March 31, 2016 | -23.30M |
| December 31, 2015 | -23.32M |
| September 30, 2015 | -25.60M |
| June 30, 2015 | -22.84M |
| March 31, 2015 | -22.33M |
| December 31, 2014 | -21.22M |
| September 30, 2014 | -17.18M |
| June 30, 2014 | -13.89M |
| March 31, 2014 | -11.31M |
| December 31, 2013 | -8.458M |
Free Cash Flow Range, Past 5 Years
-98.23M
Minimum
Dec 2019
-44.75M
Maximum
Dec 2020
-71.16M
Average
-72.98M
Median
Dec 2023
Free Cash Flow Benchmarks
| Gilead Sciences Inc | 8.481B |
| Assure Holdings Corp | -5.044M |
| Societal CDMO Inc (DELISTED) | -9.242M |
| AN2 Therapeutics Inc | -53.29M |
| Madrigal Pharmaceuticals Inc | -325.71M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.38M |
| Cash from Investing (Quarterly) | -42.11M |
| Cash from Financing (Quarterly) | 2.729M |
| Free Cash Flow Per Share (Quarterly) | -0.2318 |
| Free Cash Flow to Equity (Quarterly) | -32.64M |
| Free Cash Flow Yield | -2.12% |